IL214757A0 - Compositions and methods to prevent and/or treat cancer with pa-card - Google Patents

Compositions and methods to prevent and/or treat cancer with pa-card

Info

Publication number
IL214757A0
IL214757A0 IL214757A IL21475711A IL214757A0 IL 214757 A0 IL214757 A0 IL 214757A0 IL 214757 A IL214757 A IL 214757A IL 21475711 A IL21475711 A IL 21475711A IL 214757 A0 IL214757 A0 IL 214757A0
Authority
IL
Israel
Prior art keywords
card
compositions
methods
prevent
treat cancer
Prior art date
Application number
IL214757A
Original Assignee
Cdg Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cdg Therapeutics Inc filed Critical Cdg Therapeutics Inc
Publication of IL214757A0 publication Critical patent/IL214757A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL214757A 2009-02-20 2011-08-18 Compositions and methods to prevent and/or treat cancer with pa-card IL214757A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15423609P 2009-02-20 2009-02-20
US17943509P 2009-05-19 2009-05-19
PCT/US2010/024904 WO2010096754A1 (en) 2009-02-20 2010-02-22 Compositions and methods to prevent and/or treat cancer with pa -card

Publications (1)

Publication Number Publication Date
IL214757A0 true IL214757A0 (en) 2011-11-30

Family

ID=42634238

Family Applications (1)

Application Number Title Priority Date Filing Date
IL214757A IL214757A0 (en) 2009-02-20 2011-08-18 Compositions and methods to prevent and/or treat cancer with pa-card

Country Status (9)

Country Link
EP (1) EP2398486A4 (en)
JP (1) JP2012518417A (en)
KR (1) KR20120000062A (en)
CN (1) CN102387809A (en)
AU (1) AU2010215858A1 (en)
CA (1) CA2753121A1 (en)
IL (1) IL214757A0 (en)
SG (1) SG174136A1 (en)
WO (1) WO2010096754A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2572952T3 (en) 2005-11-07 2016-06-03 Indiana University Research And Technology Corporation Glucagon analogs showing physiological solubility and stability
WO2014049604A2 (en) * 2012-09-05 2014-04-03 Amrita Therapeutics Limited A novel biomedical device for cancer therapy
BR112015018444A2 (en) * 2013-02-05 2018-05-08 Agricultural Technology Research Institute composition to prevent mycoplasma spp. infection, and expression vector
CN103554187B (en) * 2013-09-18 2016-03-30 中国科学技术大学 Platinum complexes, protein complex of being obtained by this platinum compound and preparation method thereof
USD844857S1 (en) * 2017-10-05 2019-04-02 Western Interlock, Inc. Retaining wall corner block

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2303800A (en) * 1999-01-26 2000-08-18 University College London Screen method
US20020164703A1 (en) * 2000-12-21 2002-11-07 Krzysztof Pawlowski Card-domain containing polypeptides, encoding nucleic acids, and methods of use
GB0211295D0 (en) * 2002-05-16 2002-06-26 Univ London Treatment of pain
KR20070108128A (en) * 2004-10-07 2007-11-08 아난다 차크라바르티 Cupredoxin derived transport agents and methods of use thereof

Also Published As

Publication number Publication date
SG174136A1 (en) 2011-10-28
KR20120000062A (en) 2012-01-03
CA2753121A1 (en) 2010-08-26
WO2010096754A8 (en) 2011-04-28
JP2012518417A (en) 2012-08-16
CN102387809A (en) 2012-03-21
WO2010096754A1 (en) 2010-08-26
AU2010215858A1 (en) 2011-09-22
EP2398486A4 (en) 2012-11-21
EP2398486A1 (en) 2011-12-28

Similar Documents

Publication Publication Date Title
IL218987A0 (en) Methods and compositions for treating cancer
IL239918A0 (en) Compositions and methods for treating colitis
EP2419137A4 (en) Compositions and methods to treat acute myelogenous leukemia
IL218212A0 (en) Therapeutic methods and compositions
IL200251A0 (en) Compositions and methods to prevent cancer with cupredoxins
HK1159498A1 (en) Methods and compositions for the treatment of cancer
EP2419136A4 (en) Compositions and methods for treating cancer
SG10201500124VA (en) Methods and Compositions for Treating Cancer
EP2504428A4 (en) Methods and compositions for treating oxalate-related conditions
EP2429584A4 (en) Methods and compositions for treatment
IL214500A0 (en) Compositions and methods for extended therapy with aminopyridines
EP2340027A4 (en) Methods and compositions for the treatment of cancer
IL215932A0 (en) Compositions and methods for treating burns
IL214349A0 (en) Compositions and methods for the treatment of cancer
GB0903299D0 (en) Composition and methods
EP2437738A4 (en) Methods and compositions for the treatment of cancer
IL214757A0 (en) Compositions and methods to prevent and/or treat cancer with pa-card
IL213636A0 (en) Compositions and methods to prevent cancer with cupredoxins
GB0901494D0 (en) Compositions and Methods
EP2411031A4 (en) Methods and compositions for the treatment of cancer
EP2547368A4 (en) Methods and compositions for the treatment of cancer
EP2461870A4 (en) Therapeutic compositions and methods
IL213657A0 (en) Compositions and methods to prevent cancer with cupredoxins
IL213919A0 (en) Methods to treat cancer
EP2582384A4 (en) Compositions and methods for treating cancer